Dietrich Stephan
2021
In 2021, Dietrich Stephan earned a total compensation of $1.5M as Ph.D., Chief Executive Officer at Ohr Pharmaceutical, a 210% increase compared to previous year.
Compensation breakdown
| Bonus | $196,875 |
|---|---|
| Option Awards | $799,886 |
| Salary | $469,149 |
| Other | $47,808 |
| Total | $1,513,717 |
Stephan received $799.9K in option awards, accounting for 53% of the total pay in 2021.
Stephan also received $196.9K in bonus, $469.1K in salary and $47.8K in other compensation.
Rankings
In 2021, Dietrich Stephan's compensation ranked 7,221st out of 12,415 executives tracked by ExecPay. In other words, Stephan earned more than 41.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,221 out of 12,415 | 42nd |
Division Manufacturing | 3,166 out of 5,505 | 43rd |
Major group Chemicals And Allied Products | 1,398 out of 2,375 | 41st |
Industry group Drugs | 1,245 out of 2,096 | 41st |
Industry Pharmaceutical Preparations | 914 out of 1,546 | 41st |
Source: SEC filing on July 22, 2022.
Stephan's colleagues
We found two more compensation records of executives who worked with Dietrich Stephan at Ohr Pharmaceutical in 2021.